Kappa Opioid Receptor (KOR) Neurons

Kappa Opioid Receptor (KOR) Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Kappa Opioid Receptor (KOR) Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Opioid Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Nucleus accumbens, Hypothalamus, Cortex, Striatum, Amygdala</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>KOR (OPRK1)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gi-coupled, inhibitory</td>
</tr>
<tr>
<td class="label">Endogenous Ligands</td>
<td>Dynorphin, β-endorphin</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">BTRX-335140</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">CERC-501</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">JNJ-67953964</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">UPF-648</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">Difelikefalin</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">Nalfurafine</td>
<td>KOR-selective</td>
</tr>
<tr>
<td clas

Kappa Opioid Receptor (KOR) Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Kappa Opioid Receptor (KOR) Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Opioid Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Nucleus accumbens, Hypothalamus, Cortex, Striatum, Amygdala</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>KOR (OPRK1)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gi-coupled, inhibitory</td>
</tr>
<tr>
<td class="label">Endogenous Ligands</td>
<td>Dynorphin, β-endorphin</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">BTRX-335140</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">CERC-501</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">JNJ-67953964</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">UPF-648</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">Difelikefalin</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">Nalfurafine</td>
<td>KOR-selective</td>
</tr>
<tr>
<td class="label">Triazole 8.1</td>
<td>KOR-selective</td>
</tr>
</table>

Kappa Opioid Receptor (Kor) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Kappa opioid receptor (KOR) neurons represent a critical population of neurons expressing the kappa opioid receptor, a Gi/o-coupled inhibitory receptor encoded by the OPRK1 gene. These neurons are widely distributed throughout the central nervous system and play complex roles in modulating mood, reward processing, pain perception, and stress responses[1][2]. The KOR system has emerged as a key player in neurodegenerative diseases, with particular relevance to Parkinson's disease, Alzheimer's disease, and related disorders. Unlike mu opioid receptor (MOR) activation which produces analgesia and euphoria, KOR activation typically induces dysphoric and aversive states, making this system therapeutically complex[1]. [@liu2019]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Properties

Receptor Structure

The kappa opioid receptor is a 380-amino acid G protein-coupled receptor (GPCR) with:

• Seven transmembrane domains typical of class A GPCRs
• High affinity for dynorphin A and dynorphin B
• Lower affinity for ketocyclazocine and U-50488H
• Alternative splicing producing multiple receptor isoforms

Signaling Pathways

KOR activation triggers multiple intracellular cascades[3]:

Genetic Variations

• SNPs in OPRK1 associated with addiction vulnerability
• Promoter polymorphisms affect dynorphin expression
• Kor1 variant linked to depression and anxiety disorders

Distribution in the Brain

Striatum and Nucleus Accumbens

The striatum and nucleus accumbens (NAc) show high KOR expression, particularly in the shell region[2]:

• Medium spiny neurons (MSNs) express KOR on both direct and indirect pathway neurons
• Modulation: KOR activation reduces dopamine release from terminals
• Relevance to PD: Dysregulated KOR signaling contributes to anhedonia in Parkinson's disease[5]

Hypothalamus

The paraventricular nucleus (PVN) and other hypothalamic regions express KOR[4]:

• Stress response: KOR modulates hypothalamic-pituitary-adrenal (HPA) axis activity
• Neuroendocrine function: Affects CRH and vasopressin release
• Metabolism: KOR influences feeding behavior and energy homeostasis

Cortex

Cortical KOR expression varies by layer:

• Layer 5 pyramidal neurons show highest expression
• Interneurons: KOR modulates cortical inhibition
• Cognitive function: KOR overactivity impairs working memory[7]

Amygdala

The amygdala contains high KOR density[1]:

• Stress-induced dysphoria: Mediated through amygdala KOR activation
• Fear conditioning: KOR modulates fear memory consolidation
• Anxiety: KOR antagonists produce anxiolytic effects

Functions in Normal Physiology

Mood and Emotion

KOR neurons play a central role in emotional processing[1]:

• Dysphoria: Endogenous dynorphin release during stress produces aversive states
• Anhedonia: KOR activation in NAc reduces reward sensitivity[2]
• Depression: KOR overactivity contributes to depressive symptoms[7]

Pain Modulation

In the spinal cord and brain, KOR provides analgesia[3]:

• Spinal analgesia: KOR agonists produce analgesia without respiratory depression
• Peripheral anti-itch: KOR activation reduces pruritus (itch)[8]
• Different tolerance profile: KOR agonists show less tolerance than MOR agonists

Reward and Motivation

The KOR system opposes the mesolimbic dopamine pathway[2]:

• Dopamine modulation: KOR activation reduces NAc dopamine release
• Reward threshold: KOR elevation increases reward threshold
• Aversion: Strong KOR activation produces aversive states

Stress Response

KOR is activated during stress[4]:

• Stress-induced analgesia: KOR mediates stress-analgesia
• HPA axis modulation: KOR affects cortisol release
• Memory consolidation: KOR modulates stress memory formation

Clinical Significance in Neurodegeneration

Parkinson's Disease

KOR neurons are critically involved in PD pathophysiology[5]:

Non-Motor Symptoms

• Depression: Elevated KOR activity contributes to depressive symptoms in PD
• Anhedonia: KOR-mediated dopamine inhibition reduces reward processing
• Anxiety: Dysregulated KOR signaling contributes to anxiety disorders

• Dyskinesias: KOR expression changes in basal ganglia with chronic levodopa[5]
• Motor fluctuations: KOR antagonists may enhance dopaminergic therapy
• Pain: KOR dysfunction contributes to pain syndromes in PD

• Dynorphin toxicity: Accumulation of dynorphin may contribute to neurodegeneration
• Therapeutic targeting: KOR antagonists being explored for neuroprotection[5]

Alzheimer's Disease

Cognitive Function[7]

• Working memory: KOR overactivity impairs prefrontal cortical function
• Synaptic plasticity: KOR activation affects LTPmechanisms/long-term-potentiation) in hippocampus
• Memory consolidation: KOR modulates memory formation

• Microglial modulation: KOR affects microglial activation states
• Neuroinflammatory response: KOR ligands modulate neuroinflammation
• Therapeutic potential: KOR antagonists may reduce neuroinflammation

Multiple System Atrophy (MSA)

• Autonomic dysfunction: KOR in PVN affects autonomic regulation[4]
• Sleep disorders: KOR modulates REM sleep behavior disorder
• Cerebellar involvement: KOR in cerebellum may affect ataxia

Huntington's Disease

• Striatal degeneration: KOR expression changes in HD striatum
• Mood symptoms: KOR contributes to depression in HD
• Motor function: KOR modulation affects chorea

Pharmacological Agents

KOR Antagonists

KOR Agonists

Peripherally-Selective KOR Agonists

• CR845: Perioperative analgesia with reduced CNS effects
• Methocinnamox: Long-acting KOR antagonist

Dynorphin and KOR in Neurodegeneration

Dynorphin Biology

Dynorphins are endogenous KOR ligands[4]:

• Dynorphin A (1-17): Highest KOR affinity
• Dynorphin B: Also activates κ3 sites
• Processing: Prodynorphin cleavage yields multiple peptides

Pathological Accumulation

In neurodegenerative diseases[6]:

• PD: Elevated dynorphin in substantia nigra
• HD: Increased prodynorphin expression in striatum
• AD: Altered dynorphin processing in hippocampus

Neurotoxicity Mechanisms

• Excitotoxicity: KOR overactivation may contribute to excitotoxicity
• Oxidative stress: Dynorphin promotes ROS production
• Apoptosis: KOR activation can trigger apoptotic pathways

Animal Models

Knockout Studies

• KOR-KO: Loss of stress-induced dysphoria, enhanced reward
• Prodynorphin-KO: Reduced aversive responses to stress
• Conditional KO: Cell-type specific deletions elucidate function

• KOR overexpression: Enhanced stress responses
• Humanized KOR: Studying human-specific variants

Research Directions

Biomarker Development

• CSF dynorphin: Potential biomarker for KOR activity
• Imaging ligands: PET tracers for KOR under development
• Peripheral markers: Platelet KOR as peripheral readout

Novel Therapeutics

Selective KOR Antagonists

• Advancement in selectivity over MOR/DOR
• Improved CNS penetration
• Reduced side effect profile[7]

• Avoid CNS-mediated dysphoric effects
• Target peripheral KOR in inflammation
• Pain and itch indications[8]

Gene Therapy Approaches

• AAV-delivered KOR constructs
• CRISPR editing of OPRK1
• RNAi targeting prodynorphin

See Also

• [Opioid Neurotransmission
• Opioid Receptors
• [Dynorphin in Neurodegeneration](/diseases/neurodegeneration)neurodegeneration)
• [Dopamine and Mood Disorders](/entities/dopamine)
• [Parkinson's Disease Non-Motor Symptoms](/diseases/parkinsons-disease)

• [Wikipedia: Opioid receptor](https://en.wikipedia.org/wiki/Opioid_receptor)
• [IUPHAR: Opioid receptors](https://www.guidetopharmacology.org/GRAC/ObjectSelectForward?objectSelectId=9&familySelectId=5)tf)
• [Cell Type Atlas: Kappa Opioid Receptor Neurons](https://portal.brain-map.org/)

Background

The study of Kappa Opioid Receptor (Kor) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/) - Single-cell expression data
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) - Mouse brain reference data](/datasets/mouse-brain-atlas)
• [Allen Human Brain Atlas](https://human.brain-map.org/microarray) - Gene expression data

Pathway Diagram

The following diagram shows the key molecular relationships involving Kappa Opioid Receptor (KOR) Neurons discovered through SciDEX knowledge graph analysis: